WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Georgia Cooper-Dervan
Associate
Regulatory
London
gcooperdervan@wsgr.com

D44-20-39634078

Download vCard
Open PDF

Georgia Cooper-Dervan is an associate in the London office of Wilson Sonsini Goodrich & Rosati. She focuses her practice on complex corporate, national security, and financial crime matters, including those relating to bribery and corruption, money laundering, financial and trade sanctions, export controls, fraud, and the application of the UK National Security & Investment Act.

Georgia regularly advises clients on a broad range of national security, white collar, international risk, and governance concerns. Her work includes conducting internal, governmental, and regulatory investigations. Georgia also provides clients with day-to-day strategic advice on compliance with anti-corruption and anti-money laundering laws, financial and trade sanctions, and national security regulations, as well as designing, implementing, and assessing financial crime compliance programs.

Experience

Georgia Cooper-Dervan is an associate in the London office of Wilson Sonsini Goodrich & Rosati. She focuses her practice on complex corporate, national security, and financial crime matters, including those relating to bribery and corruption, money laundering, financial and trade sanctions, export controls, fraud, and the application of the UK National Security & Investment Act.

Georgia regularly advises clients on a broad range of national security, white collar, international risk, and governance concerns. Her work includes conducting internal, governmental, and regulatory investigations. Georgia also provides clients with day-to-day strategic advice on compliance with anti-corruption and anti-money laundering laws, financial and trade sanctions, and national security regulations, as well as designing, implementing, and assessing financial crime compliance programs.

Education
  • LL.M., The University of Law (London), 2019With Distinction
  • LL.B., London School of Economics and Political Science, 2018First Class Honours
Admissions
  • Solicitor, England and Wales
Credentials
Education
  • LL.M., The University of Law (London), 2019With Distinction
  • LL.B., London School of Economics and Political Science, 2018First Class Honours
Admissions
  • Solicitor, England and Wales

Select Publications

  • Co-author, “How to Approach Rising Foreign Direct Investment Hurdles,” Law360, August 14, 2026
Insights

Select Publications

  • Co-author, “How to Approach Rising Foreign Direct Investment Hurdles,” Law360, August 14, 2026
Focus Areas
  • Anti-Money Laundering
  • Board and Internal Investigations
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Government Investigations
  • National Security and Trade
  • Regulatory
  • Strategic Risk and Crisis Management
  • White Collar Crime
Recent Insights
Client Highlights
Wilson Sonsini Advises World Labs on $8.2 Billion Acquisition by AMD
On September 28, 2026, AMD, a global semiconductor company, announced it has entered into a definitive agreement to acquire World Labs, an AI model and research lab led by AI pioneer Dr. Fei-Fei Li. The acquisition will bring a world-class team of researchers and model experts to AMD, strengthening its ability to develop AI hardware, software, and systems. Wilson Sonsini Goodrich & Rosati is advising World Labs on the transaction.
Learn More
Client Highlights
Firm Advises CoVet on Acquisition by IDEXX
On September 16, 2026, IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. The financial terms of the transaction were not disclosed. Wilson Sonsini Goodrich & Rosati advised CoVet on the transaction.

CoVet helps veterinary teams automatically capture and organize information across the patient care journey, from consultation to treatment planning and client follow-up, reducing documentation burden and saving clinicians’ time. The acquisition expands the value of IDEXX’s software, diagnostics, and AI offerings by making information more accessible, actionable, and connected across the practice. CoVet will be integrated into the IDEXX software ecosystem, which will continue to support other ambient scribe solutions and third-party integrations. CoVet will also continue to integrate with non-IDEXX practice management systems.

The Wilson Sonsini team that advised CoVet on the transaction included:
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.